Procaps Group SA Valuation

PROCDelisted Stock  USD 1.10  0.00  0.00%   
Today, the company appears to be overvalued. Procaps Group SA holds a recent Real Value of $1.01 per share. The prevailing price of the company is $1.1. Our model determines the value of Procaps Group SA from analyzing the company fundamentals such as Return On Equity of 0.37, shares outstanding of 112.82 M, and Operating Margin of 0.11 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
1.10
Please note that Procaps Group's price fluctuation is very steady at this time. Calculation of the real value of Procaps Group SA is based on 3 months time horizon. Increasing Procaps Group's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Procaps Group is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Procaps Stock. However, Procaps Group's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  1.1 Real  1.01 Hype  1.1
The real value of Procaps Stock, also known as its intrinsic value, is the underlying worth of Procaps Group SA Company, which is reflected in its stock price. It is based on Procaps Group's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Procaps Group's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
1.01
Real Value
1.21
Upside
Estimating the potential upside or downside of Procaps Group SA helps investors to forecast how Procaps stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Procaps Group more accurately as focusing exclusively on Procaps Group's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
1.101.101.10
Details

Procaps Group Total Value Analysis

Procaps Group SA is at this time estimated to have valuation of 2.8 B with market capitalization of 113.95 M, debt of 285.94 M, and cash on hands of 37.55 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Procaps Group fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
2.8 B
113.95 M
285.94 M
37.55 M

Procaps Group Investor Information

About 83.0% of the company outstanding shares are owned by corporate insiders. The company had not issued any dividends in recent years. Procaps Group SA had 1:1 split on the 30th of September 2021. Based on the analysis of Procaps Group's profitability, liquidity, and operating efficiency, Procaps Group SA is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.

Procaps Group Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Procaps Group has an asset utilization ratio of 89.98 percent. This indicates that the Company is making $0.9 for each dollar of assets. An increasing asset utilization means that Procaps Group SA is more efficient with each dollar of assets it utilizes for everyday operations.

Procaps Group Ownership Allocation

Procaps Group owns a total of 112.82 Million outstanding shares. Procaps Group holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 83.02 pct. of Procaps Group SA outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.

Procaps Group Profitability Analysis

The company reported the previous year's revenue of 414.1 M. Net Income was 52.2 M with profit before overhead, payroll, taxes, and interest of 227.91 M.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Procaps Group's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Procaps Group and how it compares across the competition.

About Procaps Group Valuation

The delisted stock valuation mechanism determines Procaps Group's current worth on a weekly basis. Our valuation model uses a comparative analysis of Procaps Group. We calculate exposure to Procaps Group's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Procaps Group's related companies.
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company was founded in 1977 and is based in Luxembourg, Luxembourg. Procaps Group is traded on NASDAQ Exchange in the United States.

Procaps Group Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding101.1 M
Quarterly Earnings Growth Y O Y-0.637
Forward Price Earnings81.3008
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Consideration for investing in Procaps Stock

If you are still planning to invest in Procaps Group SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Procaps Group's history and understand the potential risks before investing.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas